MedPath

Zinc Status and Growth in Cystic Fibrosis

Completed
Conditions
Cystic
Fibrosis
Registration Number
NCT04302428
Lead Sponsor
Indiana University
Brief Summary

The purpose of this study is to improve the understanding of the relationship of zinc status and growth in infants and young children who were diagnosed with cystic fibrosis via newborn screening.

Detailed Description

The objective of this study is to improve the understanding of the relationship of zinc (Zn) status and growth in infant and young people with cystic fibrosis (PWCF). The investigators hypothesize that Zn deficiency in infant and young PWCF is associated with poor growth.

Aim #2: To study the association between Zn levels in red blood cells and nutritional status in PWCF at 3 months to 3 years of age and compare it to the association between serum Zn and nutritional status in the same population. Hypothesis: Lower Zn levels in red blood cells is associated with poorer nutritional status in infant and young PWCF and is a better measure of Zn status compared to serum Zn.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Pediatric patients ages 3 months to 3 years with CF identified via new born screening
Exclusion Criteria
  • History of meconium ileus
  • History of prematurity (born prior to completing 36 weeks 6 days gestation)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Zinc Status1 day

Zn status in infant and young PWCF as measured by serum Zn and red blood cell Zn

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Riley Hospital for Children at Indiana University Health

🇺🇸

Indianapolis, Indiana, United States

Riley Hospital for Children at Indiana University Health
🇺🇸Indianapolis, Indiana, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.